Get startedLog in
    Picture of PhaseBio Pharmaceuticals logo

    PHASQ — PhaseBio Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: PhaseBio Reports Q2 Loss Per Share Of $0.60

    Picture of PhaseBio Pharmaceuticals logoPhaseBio Pharmaceuticals
    12/08/2021 13:52
    Aug 12 (Reuters) - PhaseBio Pharmaceuticals Inc  PHAS.O :
    * PHASEBIO REPORTS SECOND-QUARTER 2021 FINANCIAL RESULTS AND
RECENT BUSINESS HIGHLIGHTS
    * PHASEBIO PHARMACEUTICALS - SUBLICENSE REVENUE FOR QUARTER
WAS
$10.3 MILLION
    * PHASEBIO PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.60

Source text for Eikon:  ID:nBw9rMjLBa 
Further company coverage:  PHAS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on PhaseBio Pharmaceuticals

    See all news